��

iiCON: Infection Innovation Consortium

0 followers

‌

About iiCON: Infection Innovation Consortium A global collaborative infectious disease R&D programme, iiCON was established in 2020. Founded with government funding provided through UK Research and Innovation’s flagship Strength in Places Fund, it brings together industry, academia, and the NHS in... Read more

Industries

Life Sciences, Research

Headquarters

Liverpool, United Kingdom

Employees

Links

Org chart

Janet Hemingway

Director

Janet Hemingway

Collapse

Chief Operating Officer, Infex Therapeutics.

Giancarlo Biagini

Head Of The Department Of Tropical Disease Biology, Liverpool School Of Tropical Medicine

Professor In Chemistry And Director Of The Surface Science Research Centre At The University Of Liverpool

Director Of Experimental Medicine

Senior Corporate Communications Manager

Teams

Research and Development

5 members

Offices

Similar companies

Squarepoint Capital

15 followers

OpenAI

349 followers

La Jolla Institute for Immunology

1 follower

Redgate

11 followers

Oxford Nanopore Technologies

8 followers

Transmission

4 followers

CAE Technology Services

2 followers

Simbec-Orion

2 followers

Ashmore Group plc

2 followers

Liontrust

2 followers

Manx Telecom

2 followers

Explore companies